- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-1-mer
- Ligands
- 5 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 5 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
PTY.2: 8 residues within 4Å:- Chain A: V.89, L.92, A.96, H.97, L.144
- Chain E: V.17, V.21
- Ligands: P5S.5
5 PLIP interactions:2 interactions with chain E, 3 interactions with chain A- Hydrophobic interactions: E:V.21, A:V.89, A:L.92, A:L.144
- Hydrogen bonds: E:V.17
PTY.21: 8 residues within 4Å:- Chain E: Q.54, L.82, I.118, V.122, H.125, N.126, L.225
- Ligands: PTY.22
8 PLIP interactions:8 interactions with chain E- Hydrophobic interactions: E:L.82, E:I.118, E:I.118, E:V.122, E:H.125, E:L.225
- Hydrogen bonds: E:Q.54
- Salt bridges: E:H.125
PTY.22: 10 residues within 4Å:- Chain E: W.65, H.125, V.222, N.223, L.225, S.226, T.229, W.231, Y.1254
- Ligands: PTY.21
5 PLIP interactions:5 interactions with chain E- Hydrophobic interactions: E:L.225, E:W.231, E:W.231, E:Y.1254
- Salt bridges: E:H.125
PTY.23: 8 residues within 4Å:- Chain E: V.86, I.89, A.90, I.93, G.97, Y.356, V.357, V.360
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:V.86, E:I.89, E:Y.356, E:V.357, E:V.360
- Hydrogen bonds: E:G.97
PTY.24: 6 residues within 4Å:- Chain E: L.318, C.319, F.321, L.352, L.361, L.451
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:L.318, E:L.361, E:L.361, E:L.451
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.3: 12 residues within 4Å:- Chain A: M.88, W.91, H.115, S.116, F.117
- Chain E: L.3, A.4, F.5, Y.15, L.104, M.108, M.112
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain E- Hydrogen bonds: A:W.91, A:F.117, E:F.5, E:Y.15
POV.7: 8 residues within 4Å:- Chain A: I.146
- Chain B: L.84, M.88, W.91, H.115, S.116, F.117, S.118
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:L.84, B:F.117, A:I.146, A:I.146
- Hydrogen bonds: B:F.117
POV.11: 7 residues within 4Å:- Chain B: P.143
- Chain C: M.88, W.91, H.115, S.116, F.117, S.118
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:F.117
POV.15: 6 residues within 4Å:- Chain D: L.84, W.91, H.115, S.116, F.117, S.118
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:L.84, D:F.117, D:F.117
- Hydrogen bonds: D:F.117
- 9 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
P5S.4: 16 residues within 4Å:- Chain A: K.67, W.68, P.69, L.72, T.76, H.175, R.176
- Chain D: V.59, F.60, L.147, V.151, I.154, V.155, M.158, I.162
- Ligands: P5S.13
12 PLIP interactions:7 interactions with chain A, 5 interactions with chain D- Hydrophobic interactions: A:L.72, A:L.72, A:T.76, D:L.147, D:L.147, D:I.154, D:V.155, D:I.162
- Hydrogen bonds: A:W.68, A:R.176
- Salt bridges: A:K.67, A:R.176
P5S.5: 14 residues within 4Å:- Chain A: L.56, Q.57, F.86, V.151
- Chain B: K.67, R.176
- Chain E: I.46, F.132, K.134, L.135, I.137, A.138
- Ligands: PTY.2, P5S.8
6 PLIP interactions:2 interactions with chain B, 1 interactions with chain E, 3 interactions with chain A- Salt bridges: B:K.67, B:R.176
- Hydrophobic interactions: E:I.46, A:F.86, A:V.151
- Hydrogen bonds: A:Q.57
P5S.8: 20 residues within 4Å:- Chain A: Q.57, V.59, F.60, I.154, V.155, M.158, I.162
- Chain B: V.64, D.65, L.66, K.67, W.68, P.69, L.72, L.73, T.76, K.170, H.175, R.176
- Ligands: P5S.5
16 PLIP interactions:4 interactions with chain A, 12 interactions with chain B- Hydrophobic interactions: A:V.59, A:F.60, A:I.154, A:I.162, B:W.68, B:W.68, B:W.68, B:L.72, B:L.73, B:T.76
- Hydrogen bonds: B:K.67, B:W.68
- Salt bridges: B:K.67, B:K.170, B:H.175, B:R.176
P5S.9: 6 residues within 4Å:- Chain B: L.56, Q.57, V.59, L.85
- Chain C: R.176
- Ligands: P5S.12
6 PLIP interactions:3 interactions with chain C, 3 interactions with chain B- Hydrogen bonds: C:R.176, C:R.176, B:Q.57
- Salt bridges: C:R.176
- Hydrophobic interactions: B:L.56, B:V.59
P5S.12: 12 residues within 4Å:- Chain B: V.151, V.155, M.158, I.159, I.162
- Chain C: K.67, W.68, P.69, L.72, L.73, R.176
- Ligands: P5S.9
14 PLIP interactions:5 interactions with chain B, 9 interactions with chain C- Hydrophobic interactions: B:V.151, B:V.155, B:M.158, B:I.159, B:I.162, C:P.69, C:L.72, C:L.73, C:L.73
- Hydrogen bonds: C:K.67, C:R.176
- Salt bridges: C:H.175, C:R.176, C:R.176
P5S.13: 7 residues within 4Å:- Chain A: R.176
- Chain D: L.56, Q.57, V.59, F.86, V.151
- Ligands: P5S.4
6 PLIP interactions:4 interactions with chain D, 2 interactions with chain A- Hydrophobic interactions: D:V.59, D:F.86, D:V.151
- Hydrogen bonds: D:Q.57
- Salt bridges: A:K.67, A:R.176
P5S.16: 17 residues within 4Å:- Chain C: L.147, I.150, V.151, I.154, V.155, M.158, I.162
- Chain D: K.67, W.68, P.69, L.72, L.73, T.76, M.77, H.175, R.176
- Ligands: P5S.17
11 PLIP interactions:5 interactions with chain C, 6 interactions with chain D- Hydrophobic interactions: C:L.147, C:I.150, C:I.154, C:V.155, C:M.158, D:L.72, D:L.72, D:T.76
- Hydrogen bonds: D:W.68, D:R.176
- Salt bridges: D:R.176
P5S.17: 10 residues within 4Å:- Chain C: L.56, Q.57, V.59, S.82, L.85
- Chain D: P.69, H.70, L.73, R.176
- Ligands: P5S.16
6 PLIP interactions:4 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:P.69, D:L.73, C:L.56, C:L.85
- Salt bridges: D:R.176, D:R.176
P5S.25: 18 residues within 4Å:- Chain E: N.72, I.76, F.79, I.80, L.224, L.225, K.227, G.228, R.298, L.301, F.305, L.364, L.368, T.371, F.372, A.375, V.379, Y.1254
17 PLIP interactions:17 interactions with chain E- Hydrophobic interactions: E:I.76, E:F.79, E:F.79, E:F.79, E:I.80, E:L.224, E:K.227, E:F.305, E:L.364, E:L.368, E:T.371, E:F.372, E:F.372, E:A.375
- Hydrogen bonds: E:R.298
- Salt bridges: E:K.227, E:R.298
- 1 x GBM: 5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide(Non-covalent)
GBM.18: 17 residues within 4Å:- Chain A: R.4
- Chain E: R.306, Y.377, I.381, W.430, F.433, L.434, N.437, P.589, L.592, D.1193, S.1238, L.1241, T.1242, N.1245, R.1246, R.1300
13 PLIP interactions:13 interactions with chain E- Hydrophobic interactions: E:Y.377, E:Y.377, E:I.381, E:F.433, E:L.592, E:L.1241
- Hydrogen bonds: E:R.306, E:N.437, E:T.1242, E:N.1245, E:R.1246, E:R.1246
- pi-Stacking: E:Y.377
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sung, M.W. et al., Ligand-mediated Structural Dynamics of a Mammalian Pancreatic K ATP Channel. J.Mol.Biol. (2022)
- Release Date
- 2022-08-31
- Peptides
- ATP-sensitive inward rectifier potassium channel 11: ABCD
ATP-binding cassette sub-family C member 8: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-1-mer
- Ligands
- 5 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 5 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 9 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
- 1 x GBM: 5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide(Non-covalent)
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sung, M.W. et al., Ligand-mediated Structural Dynamics of a Mammalian Pancreatic K ATP Channel. J.Mol.Biol. (2022)
- Release Date
- 2022-08-31
- Peptides
- ATP-sensitive inward rectifier potassium channel 11: ABCD
ATP-binding cassette sub-family C member 8: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.